The FDA approved Zepbound for medical weight loss use in adults over the age of 18 with a minimum body mass index of at least 30 or a BMI of 27+ if the person also has any other weight-related issue, like high blood pressure, heart disease, or obstructive sleep apnea
non-Nourish patients) of Nourish patients on GLP-1s lost at least 5% weight of Nourish patients on GLP-1s lost at least 10% body weight of Nourish patients on GLP-1s reported improved side effects since working with their RD of Nourish patients who discontinued GLP-1s found their Nourish RD helpful in maintaining weight loss Read more on how Nourish has helped patients on GLP-1s optimize for the greatest results in our white paper Why GLP-1 patients love Nourish Frequently asked questions Still deciding if were right for you
Our independent practitioners offer personalized care with favorable pricing structures
Making Semaglutide Affordable Navigating semaglutide costs, especially in Gallup, can be challenging without guidance
In addition, being overweight may cause concomitant pathological conditions that also prevent conception
The drug functions by mimicking the GLP-1 hormone to control blood sugar levels